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Abstract. 
 
The macrophage colony stimulating factor
 
(M-CSF) and 
 
a
 
v
 
b
 
3
 
 integrins play critical roles in osteo-
clast function. This study examines M-CSF– and adhe-
sion-induced signaling in prefusion osteoclasts (pOCs)
derived from Src-deﬁcient and wild-type mice. Src-deﬁ-
cient cells attach to but do not spread on vitronectin
(Vn)-coated surfaces and, contrary to wild-type cells,
their adhesion does not lead to tyrosine phosphory-
lation of molecules activated by adhesion, including
PYK2, p130
 
Cas
 
, paxillin, and PLC-
 
g
 
. However, in re-
 
sponse to M-CSF, Src
 
2/2
 
 
 
pOCs spread and migrate on
 
Vn in an 
 
a
 
v
 
b
 
3
 
-dependent manner. Involvement of
PLC-
 
g
 
 activation is suggested by using a PLC inhibitor,
 
U73122, which blocks both adhesion- and M-CSF–
mediated cell spreading. Furthermore, in Src
 
2/2
 
 pOCs
M-CSF, together with ﬁlamentous actin, causes recruit-
ment of 
 
b
 
3
 
 integrin and PLC-
 
g
 
 to adhesion contacts and
induces stable association of 
 
b
 
3
 
 integrin with PLC-
 
g
 
,
phosphatidylinositol 3-kinase, and PYK2. Moreover,
direct interaction of PYK2 and PLC-
 
g
 
 can be induced
by either adhesion or M-CSF, suggesting that this inter-
action may enable the formation of integrin-associated
complexes. Furthermore, this study suggests that in
pOCs PLC-
 
g
 
 is a common downstream mediator for
adhesion and growth factor signals. M-CSF–initiated
signaling modulates the 
 
a
 
v
 
b
 
3
 
 integrin-mediated cyto-
skeletal reorganization in prefusion osteoclasts in the
absence of c-Src, possibly via PLC-
 
g
 
.
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Introduction
 
Integrins are transmembrane heterodimeric glycoproteins
 
consisting of 
 
a
 
 and 
 
b
 
 subunits that mediate cell–cell and
cell–matrix interactions. Ligand binding to integrins acti-
vates signal transduction pathways which lead to de novo
gene expression and cytoskeletal rearrangement associ-
ated with cell adhesion, spreading, and migration (Thomas
and Brugge, 1997; Giancotti and Ruoslahti, 1999). It has
been shown that integrins activate multiple signaling
 
pathways including elevation of intracellular Ca
 
2
 
1
 
, lipid
turnover, and tyrosine phosphorylation. The proteins
which are tyrosine phosphorylated by extracellular matrix
(ECM)
 
1
 
–integrin interactions include the focal adhesion
kinases (FAKs) or PYK2/CAK
 
b
 
/RAFTK/CADTK, in cer-
tain cell types, p130
 
Cas
 
, and cytoskeletal molecules such as
paxillin, tensin, and cortactin (Thomas and Brugge, 1997;
Giancotti and Ruoslahti, 1999; Schlaepfer et al., 1999).
Several lines of evidence indicate that integrin-mediated
signals synergize with growth factor responses to produce
the structural changes associated with cell migration, pro-
liferation, and differentiation (Sastry and Horwitz, 1996;
Giancotti and Ruoslahti, 1999; Sieg et al., 2000). First,
many signaling molecules found in integrin-dependent fo-
cal adhesions, such as Src or phosphatidylinositol 3-kinase
(PI 3-kinase), are also known to associate with tyrosine ki-
nase growth factor receptors (Schwartz and Ingber, 1994;
Yamada and Miyamoto, 1995). Second, adhesion of most
nontransformed cells to ECM is required for cellular re-
sponses to growth factor stimulation and, in some in-
stances, directly regulates growth factor expression (Soldi
et al., 1999). Third, growth factors and integrins often re-
ciprocally regulate cellular responses such as cell migration
(Plopper et al., 1995; Filardo et al., 1996; Sieg et al., 2000).
 
Osteoclasts are macrophage-related multinucleated cells
responsible for the degradation of mineralized matrix (Suda
et al., 1996). Their adhesion to the bone surface induces the
cytoskeletal reorganization associated with activation, sug-
gesting that recognition of bone ECM proteins is an impor-
tant step in the initiation of osteoclastic bone resorption
(Duong and Rodan, 1998). Although osteoclasts express
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a
 
2
 
b
 
1
 
 and 
 
a
 
v
 
b
 
1
 
 integrins, their predominant integrin is 
 
a
 
v
 
b
 
3
 
.
Disintegrins, 
 
a
 
v
 
b
 
3
 
 blocking antibodies, and RGD peptide
mimetics have been shown to inhibit bone resorption in
vitro and in vivo
 
. 
 
We reported that PYK2 and p130
 
Cas
 
 are
key effectors in the 
 
a
 
v
 
b
 
3
 
 integrin–mediated signaling path-
ways, and their activation requires c-Src in osteoclasts
(Duong et al., 1998; Lakkakorpi et al., 1999). Osteoclasts
are also target cells for several cytokines and growth fac-
tors, among which macrophage colony stimulating factor
(M-CSF) is essential for both osteoclast development and
function (Felix et al., 1994). A role for M-CSF in osteoclast
formation was first identified in the osteopetrotic 
 
op/op
 
mice. Subsequent reports showed that mature osteoclasts
also contain the M-CSF receptor,
 
 c-fms
 
, which is required
for the survival, spreading, and migration of these cells.
The object of this study was to investigate interactions
between 
 
a
 
v
 
b
 
3
 
 integrin–mediated and M-CSF–dependent
signaling pathways in osteoclasts. We found that Src-defi-
cient prefusion osteoclasts (pOCs) adhered to, but failed
to spread on vitronectin (Vn)-coated surfaces. 
 
a
 
v
 
b
 
3
 
 inte-
grin–mediated signaling was abolished in these cells since
several adhesion-dependent molecules including PYK2,
p130
 
Cas
 
, PLC-
 
g
 
, and paxillin were not tyrosine phosphory-
lated upon attachment to Vn. However, M-CSF induced
cell spreading of Src-deficient pOCs in an integrin-depen-
dent manner, and an inhibitor of PLC-
 
g
 
 blocked the
M-CSF–dependent cell spreading. In addition, we found
that in Src-deficient cells, M-CSF initiated the recruitment
of 
 
a
 
v
 
b
 
3
 
 integrin and PLC-
 
g
 
 to adhesion contacts. M-CSF
also induced the association of 
 
a
 
v
 
b
 
3
 
 integrin with several
signaling molecules including PLC-
 
g
 
, PI 3-kinase, and
PYK2 in a Src-independent manner, which was blocked by
a PLC inhibitor. The interaction between 
 
a
 
v
 
b
 
3
 
 and these
molecules in pOCs seems to depend on the association of
PYK2 and PLC-
 
g
 
. These data suggest that PLC-
 
g
 
 is an im-
portant effector of 
 
a
 
v
 
b
 
3
 
- and M-CSF–mediated signaling
pathways involved in prefusion osteoclast spreading.
 
Materials and Methods
 
Antibodies and Other Reagents
 
Vn and poly-
 
L
 
-lysine (PL) were from GIBCO BRL and Sigma-Aldrich,
respectively. Antibodies to PYK2 (N-19), PLC-
 
g
 
1 (1249 and mAb E-12),
PLC-
 
g
 
2 (Q20 and mAb B-10), phospho–extracellular signal–regulated ki-
nase (ERK) (E-4), and ERK2 (C-14) were from Santa Cruz Biotechnol-
ogy, Inc. Antibodies to p130
 
Cas
 
 (mAb 21), paxillin (mAb 349), PYK2
(mAb 11), and phosphotyrosine (mAb PY20) were from Transduction
Labs. Anti–
 
b
 
3
 
 integrin antibodies (mAb 2C9.G2) were from BD PharMin-
gen. Anti-Akt/PKB and anti–phospho-Akt/PKB antibodies were from
New England Biolabs, Inc. Anti–phosphotyrosine antibody (mAb 4G10)
was from Upstate Biotechnology. Other conjugated secondary antibodies
were from Jackson ImmunoResearch Laboratories and Amersham Phar-
macia Biotech. Glutathione 
 
S
 
-transferase (GST) fusion proteins of PLC-
 
g
 
1 were from Santa Cruz Biotechnology, Inc. Collagenase was from Wako
Chemicals and dispase from Boehringer. 1
 
a
 
,25-dihydroxyvitamin D
 
3
 
(1
 
a
 
,25[OH]
 
2
 
D
 
3
 
) was a gift from Dr. M. Uskokovic (Hoffmann-LaRoche,
Nutley, NJ). Mouse recombinant M-CSF was from R&D Systems. Wort-
mannin, LY294002, U73122, and PD98059 were purchased from Calbio-
chem. Echistatin and polyclonal anti-
 
b
 
3 integrin antibodies were gener-
ously provided by Drs. W.K. Herber and B. Bednar (Merck Research
Laboratories, West Point, PA).
 
Animals
 
Balb/C mice were obtained from Taconic Farms. Heterozygote Src
 
1
 
/
 
2
 
mice were obtained from The Jackson Laboratory and Src
 
2/2
 
 mice were
 
phenotypically distinguished from their Src
 
1
 
/?
 
 siblings by lack of tooth
eruption. All animals were cared and housed under conditions approved
by the Institutional Animal Care and Use Committee Guide.
 
Cell Cultures
 
Prefusion osteoclast-like cells (pOCs) and multinucleated osteoclast-like
cells (OCLs) were prepared as described previously with slight modifica-
tions (Duong et al., 1998). In brief, spleen cells isolated from 2–3-wk-old
Src
 
2
 
/
 
2
 
 or their normal littermates were cocultured with osteoblastic
MB1.8 cells for 5–6 d in the presence of 10 nM 1
 
a
 
,25(OH)
 
2
 
D
 
3
 
.
 
 
 
pOCs were
released from dishes with 10 mM EDTA after removing MB1.8 cells with
collagenase-dispase. Alternatively, cocultures were kept for 7–8 d to
achieve OCLs and purified as described previously (Duong et al., 1998).
 
Cell Adhesion
 
After isolation, pOCs (3 
 
3
 
 10
 
5 
 
cells/condition) were washed twice with se-
rum-free 
 
a
 
-MEM containing 0.1% BSA (Sigma-Aldrich) and kept in sus-
pension or allowed to attach to polystyrene dishes coated with Vn (20 
 
m
 
g/
ml) or PL (50 
 
m
 
g/ml). After 5–60 min at 37
 
8
 
C, an equal volume of 2
 
3
 
 TNE
lysis buffer (20 mM Tris, pH 7.8, 300 mM NaCl, 2 mM EDTA, 2% NP-40,
2 mM NaVO
 
3
 
, 20 mM NaF, 20 
 
m
 
g/ml leupeptin, 1 TIU/ml aprotinin, and 2
mM PMSF) was added to the plates. For coimmunoprecipitation, 1.5 
 
3
 
10
 
6 
 
cells/condition and 1
 
3
 
 TNE lysis buffer with 10% glycerol (10 nM
Tris, pH 7.8, 300 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mM NaVO
 
3
 
, 10
mM NaF, 10 
 
m
 
g/ml leupeptin, 0.5 TIU/ml aprotinin, and 1 mM PMSF)
were used. In some experiments, pOCs were recultured for 12 h with
1
 
a
 
.25(OH)
 
2
 
D
 
3
 
-pretreated osteoblastic MB1.8 cells to form multinucleated
OCLs, which were subsequently purified by removing MB1.8 cells using
collagenase/dispase, as described. Clarified lysates were subjected to im-
munoprecipitation and immunoblotting. Alternatively, cells were fixed
and stained for tartrate resistant acid phosphatase (TRAP), a marker en-
zyme of osteoclasts (Nakamura et al., 1999). To quantify cell area, the pe-
riphery of each cell was outlined and the total planar area was calculated
using an image analysis system (Empire Imaging Analyzing Systems).
 
Immunoblotting and Immunoprecipitation
 
Immunoprecipitation and immunoblotting were performed as described
previously (Duong et al., 1998). In brief, lysates were precipitated with
anti-PYK2, p130
 
Cas
 
, paxillin, PLC-
 
g
 
1, PLC-
 
g
 
2, or integrin 
 
b
 
3
 
 antibodies (2
 
m
 
g) for 2 h at 4
 
8
 
C, followed by protein G–Sepharose for 1 h at 4
 
8
 
C. After
washing four times with lysis buffer, proteins were separated on an 8%
SDS-PAGE and blotted onto Immobilon-P membrane. After blocking
with 100 mM NaCl, 10 mM Tris, 0.1% Tween-20, and 2% BSA, the mem-
brane was incubated with primary antibodies, followed by HRP-conju-
gated secondary antibodies and detected with the ECL chemilumines-
cence system (Amersham Pharmacia Biotech). Levels of proteins in
immunoblots were quantitated using an Imaging Densitometer (model
GS-700, BioRad) and specific activity of tyrosine phosphorylated proteins
at various time points were estimated from the ratio of phosphorylated
proteins to its protein content, and expressed relative to controls at time 0.
 
In Vitro Protein Association Assays
 
These experiments were performed with GST fusion proteins containing
the Src homology (SH) 3 domain, SH2 domains, both SH2 domains, and
SH3 domain of PLC-
 
g
 
1. Multinucleated osteoclast-like cell lysates (1 mg/
ml) were incubated with GST fusion protein coupled with glutathione-
Sepharose beads for 2 h at 4
 
8
 
C. The beads were washed three times with
lysis buffer and one time with PBS, and precipitated proteins were sepa-
rated by SDS-PAGE and subjected to immunoblot analysis using anti-
PYK2 antibodies as described above.
 
Immunofluorescence
 
Src-deficient pOCs were cultured for 1 h on glass coverslips. After cells
were treated with 5 nM M-CSF for another 30 min, cells were fixed with
4% paraformaldehyde, permeabilized with 0.5% Triton X-100 in PBS, and
incubated for 30 min at 378C with polyclonal anti–b3 integrin (Nakamura et
al., 1999) and monoclonal anti–PLC-g1 or anti–PLC-g2 antibodies. Cells
were washed with PBS and incubated for 30 min at 378C with TRITC-con-
jugated donkey anti–rabbit IgG and FITC goat anti–mouse IgG. Samples
were viewed with a Leica TCS SP Spectral confocal laser scanning micro-
scope equipped with Argon-Krypton laser (Leica Microsystems). Nakamura et al. Cross-regulation of avb3 and M-CSFR in Osteoclasts 363
Cell Migration
Migration assay was performed as described by Nakamura et al. (1999), in
which Src1/? or Src2/2 pOCs were cultured on Vn-coated dishes in me-
dium 199 (25 mM Hepes, 4 mM HCO3
2, supplemented with 0.1% FBS),
covered with paraffin oil, and maintained at 358C using a stage heater. Os-
teoclasts were observed using an inverted phase–contrast microscope cou-
pled to a video camera and time-lapse video recorder (one frame per 2 s).
Using M-CSF as a chemotactic stimulus, osteoclast migration was moni-
tored. A micropipette containing M-CSF (1 nM) was positioned 200–400
mm from the cells and contents were delivered by a syringe pump at the
rate of 4 ml/h (Harvard Apparatus). Osteoclast responses were recorded
for 4 h by time-lapse video microscopy. Images of pOCs were digitized us-
ing an analysis system (Empire Imaging Systems) and migration was
quantified as the net movement of the cell centroid during a culture pe-
riod of 4 h.
Results
M-CSF Induces Cell Spreading and Migration of Src2/2 
Osteoclasts in an avb3 Integrin–dependent Manner
Fibroblasts from Src-deficient mice were shown to have a
reduced rate of spreading on fibronectin (Kaplan et al.,
1995). We found that the pOCs derived from Src2/2 mice
exhibit a profound defect in cell spreading on Vn-coated
surfaces (Fig. 1). Wild-type pOCs fully spread within 60
min of plating (Fig. 1, left), whereas Src2/2 pOCs re-
mained rounded at 60 min (Fig. 1, right), and up to 120
min (data not shown). Spreading area of wild-type and
Src-deficient pOC on Vn were quantitated and are shown
in Fig. 1 I. Initial attachment to Vn appeared to be normal
in Src2/2 pOCs; however, these cells were easily detached
by shaking and tapping, indicating that the firm adhesion
associated with cell spreading did not occur, although the
expression level of avb3 integrins and their binding affinity
were not altered in Src2/2 pOCs (Lakkakorpi et al., 2000).
The highest number of Src2/2 pOCs attached to Vn-
coated dishes was observed 60 min after seeding.
It has been shown that the M-CSF receptor, c-Fms, is ex-
pressed in mature osteoclasts and that M-CSF induces cell
spreading and cell migration in rat primary osteoclasts and
murine osteoclast-like cells (Felix et al., 1994). To deter-
mine whether c-Src function is required for M-CSF–
induced cytoskeletal reorganization during cell spreading
and migration, Src-deficient and wild-type pOCs were
plated on Vn-coated dishes and treated with M-CSF. To
obtain optimal numbers of attached cells, we first allowed
Src2/2 cells to adhere to Vn-coated surfaces for 60 min
prior to M-CSF addition. Although Src2/2 pOCs did not
spread spontaneously on Vn, M-CSF rapidly induced Src2/2
cell spreading (Figs. 2 A and 3, first and second bars).
Moreover, M-CSF induced the formation of small punctate
adhesion contacts in Src2/2 pOCs, similar to podosomal
adhesion structures found in wild-type cells (Fig. 3 B). Be-
cause a previous study found that 2.5 nM M-CSF did not
induce cell spreading of nonpurified primary Src-deficient
osteoclasts (Insogna et al., 1997), we examined cell spread-
ing of wild-type and Src2/2 pOCs at 0, 2.5 and 5.0 nM
M-CSF (n 5 50), to rule out a dose effect phenomenon. The
cell area of untreated wild-type cells was 234 6 41 mm2 and
of Src2/2 pOCs, 93 6 15 mm2. M-CSF at 2.5 nM increased
the cell area in wild-type to 279 ± 16 mm2 (119%) and in
Src2/2 pOC to 203 6 22 mm2 (218%), respectively; while 5
nM M-CSF increased cell spreading area to 318 6 25 mm2
Figure 1. Src2/2 pOCs do not spread on Vn-coated dishes. Src1/?
(A, C, E, and G) and Src2/2 (B, D, F, and H) pOCs were plated
on Vn (20 mg/ml). After culture for 5 (A and B), 15 (C and D), 30
(E and F), and 60 (G and H) min, cells were fixed and photo-
graphed. (I) To quantify cell area, the periphery of each cell was
outlined and the total planar area was calculated, using an image
analysis system (Empire Imaging Systems). Data are expressed
as the means of 6 SEM of .50 cells.The Journal of Cell Biology, Volume 152, 2001 364
(135%) in wild-type and 270 6 27 mm2 (290%) in Src2/2
pOC, respectively; i.e. at both doses, there was a pro-
nounced effect on the spreading of Src2/2 pOCs, and not of
wild-type pOCs.
Furthermore, M-CSF–stimulated osteoclast chemotaxis
of Src-deficient cells was not different from wild-type cells
(Fig. 4). In control cultures 15 out of 26 (58%) Src1/? pOCs
migrated towards the source of M-CSF, and the net migra-
tion distance over a 4-h period was 25.5 6 2.0 mm
(means  6 SEM). Similarly, 10 out of 19 (53%) Src2/2
pOCs showed chemotactic migration, and the net distance
was 24.5 6 2.9 mm, not significantly different from wild-
type. These observations suggest that Src function is not re-
quired for the M-CSF–induced cytoskeletal reorganization
required for osteoclast spreading and migration.
To further examine the role of avb3 integrin in M-CSF–
induced Src2/2 pOC spreading, cells were plated on Vn- or
PL-coated dishes in the presence of M-CSF under serum-
free conditions. As shown in Fig. 3, M-CSF–induced cell
spreading of Src2/2 pOCs only when cells were plated on
Vn, but not on PL. It should be noted that wild-type pOCs
plated on PL do not spread either in the absence or pres-
ence of M-CSF (data not shown). Moreover, M-CSF–
induced Src-deficient pOC cell spreading on Vn was
blocked by the RGD-containing disintegrin, echistatin (Fig.
3) which was previously demonstrated to have high bind-
ing affinity for avb3 and to inhibit avb3-mediated spread-
ing, migration, and sealing zone formation in osteoclasts
(Nakamura et al., 1999). This finding suggested that in the
absence of c-Src, M-CSF-initiated cytoskeletal rearrange-
ment to during cell spreading and migration still depends
Figure 2. M-CSF induces cell
spreading of Src2/2 pOCs on
Vn-coated dishes. (A) Src2/2
pOCs were plated on Vn-
coated dishes in the absence
of serum for 60 min, cells
were then treated with 5 nM
M-CSF for 0 (a), 2 (b), 5 (c),
15 (d), and 30 (e) min, with-
out or with (f) 100 nM wort-
mannin. (B) Src1/? (a) and
Src2/2 (b and c) pOCs were
plated on Vn for 60 min, un-
treated (a and b) or treated
with 5 nM M-CSF treatment
for additional 30 min (c).
Cells were fixed and stained
with rhodamine-conjugated
phalloidin. Bars: (A) 10 mm;
(B) 5 mm.
Figure 3. M-CSF–induced cell spreading of Src2/2 pOCs is de-
pendent on avb3 integrin. Src2/2 pOCs were plated on Vn or PL
in serum-free condition. After 60 min, cells were treated with 5
nM M-CSF for 30 min in the absence or presence of echistatin (1
nM). Cells were fixed and stained for TRAP activity, followed by
quantitating cell area as described above. Data are presented as
means 6 SEM and n 5 50 cells per group.Nakamura et al. Cross-regulation of avb3 and M-CSFR in Osteoclasts 365
on ligand engagement of avb3 integrins. We had previously
shown that tyrosine phosphorylation of PYK2 and p130Cas,
avb3-associated downstream signaling molecules, is signifi-
cantly diminished in Src-deficient OCLs (Duong et al.,
1998; Lakkakorpi et al., 1999). We therefore searched for
potential downstream participants, which could modulate
the synergistic action of the adhesion- and M-CSF-medi-
ated cytoskeletal reorganization in Src-deficient pOCs and
evaluated include PI 3-kinase and PLC.
Inhibitors of PLC and PI 3-Kinase Block Adhesion-
and M-CSF–induced Cell Spreading of
Src-deficient Osteoclasts
We examined the involvement of PI 3-kinase and PLC-g
in M-CSF–mediated signaling in Src-deficient cells using
either wortmannin (0.1 mM) or U73122 (1 mM). As shown
in Fig. 5 A (bars 5–7) and Fig. 2 F, either inhibitor blocked
M-CSF–induced cell spreading in Src2/2 pOCs. Both in-
hibitors also blocked the migration of wild-type and Src-
deficient cells assessed by time-lapse video microscopy
(data not shown). Similarly, cell spreading of wild-type
pOCs upon adhering to Vn was also inhibited by wort-
mannin (data not shown) and U73122 (Fig. 5 A, bars 1
and 2). Although U73122 is widely used as a PLC inhibi-
tor, it has been shown to interfere with non PLC-depen-
dent signals, usually at higher concentrations (.10 mM)
(Walker et al., 1998). Nevertheless, our pharmacological
findings suggest that PI 3-kinase and PLC-g may take part
in both adhesion-dependent and M-CSF–mediated signal-
ing, which leads to cytoskeletal organization in prefusion
osteoclasts.
Interestingly, PD98059, a mitogen-activated protein
(MAP) kinase kinase inhibitor, had little effect on the
spreading of Src2/2 pOCs (Fig. 5 A, bars 5 and 8), although
activation of ERK1 and 2 were induced by attachment to
Vn-coated surface and by M-CSF treatment in wild-type
pOCs using phospho-ERK–specific antibodies (Fig. 5 B,
right). However, these kinases were not activated by either
Figure 4. M-CSF induces cell
migration of Src2/2 pOCs as
well as wild-type cells. The
motility of Src1/? and Src2/2
pOCs was monitored using
time-lapse video microscopy,
as described in Materials and
Methods. M-CSF (1 nM) was
supplied through a micropi-
pette to induce chemotaxis.
Cells were observed using an
inverted phase–contrast mi-
croscope coupled to a video
camera and time-lapse video
recorder. Images of cells
were digitized using a com-
puter-based image analysis
system. Migration activity
(net translocation of the cell
center over a period of 4 h)
was quantified (filled circles).
15 out of 26 (58%) Src1/?
cells and 10 out of 19 (53%) Src2/2 cells migrated towards the
source of M-CSF. Means 6 SEM (open circles) of migrating dis-
tance of wild-type and Src2/2 cells are shown.
Figure 5. PLC and PI 3-kinase inhibitors block adhesion-induced
and M-CSF–induced cell spreading of prefusion osteoclast-like
cells. (A) Src1/? pOCs (1, 2, and 4) and Src2/2 pOCs (3 and 5–8)
were plated on Vn under serum-free condition. After 60 min,
cells were treated with (4–8) or without (1–3) M-CSF for 30 min.
U73122 (2 and 6), wortmannin (7), or PD98059 (8) was preincu-
bated for 40 min before M-CSF was added. Cells were fixed,
stained for TRAP, and the total planar area was calculated as de-
scribed in Materials and Methods. Data are presented as
means  6 SEM; n 5 50 cells
per group. (B) Src1/? and
Src2/2 pOCs were kept in
suspension or plated on Vn
for 60 min in the absence of
serum, followed by the treat-
ment with 5 nM M-CSF for
indicated periods with or
without 10 mM PD98059.
Lysates were blotted with
anti–phospho-ERK (top),
followed by anti-ERK and
anti-Src (bottom). Susp., sus-
pension; Att., attachment.The Journal of Cell Biology, Volume 152, 2001 366
pathway in Src2/2 pOCs (Fig. 5 B, left). These findings sug-
gest that adhesion- and M-CSF–dependent activation of
the MAP kinases require c-Src in pOCs. However, in Src-
deficient prefusion osteoclasts their activation did not cor-
relate with M-CSF–induced cytoskeletal rearrangement.
Adhesion-mediated Protein Tyrosine Phosphorylation Is 
Impaired in Src-deficient Osteoclasts
Initial events triggered by integrin engagement of ECM
ligands include recruitment and phosphorylation of numer-
ous signaling and cytoskeletal molecules, leading to cyto-
Figure 6. Adhesion-induced tyrosine phosphorylation of PYK2,
Cas, paxillin, and PLC-g in Src1/? and Src2/2 prefusion osteoclast-
like cells. (A) Src1/? pOCs were kept in suspension for 60 min or plated on Vn-coated
dishes for the indicated periods in the absence of serum. Total cell lysates were immu-
noprecipitated (IP) with anti-PYK2, anti-Cas, anti–paxillin, anti–PLC-g1 and 2, and
anti-Src antibodies, followed by immunoblotting with anti–phosphotyrosine (pTyr)
antibody (left). The same membranes were reblotted with anti-PYK2, anti-Cas, anti–
paxillin, anti–PLC-g1 and 2, and anti-Src antibodies (right). (B) Src1/? or Src2/2 pOCs
were kept in cell suspension or plated on Vn for 60 min. Total cell lysates were sub-
jected to immunoprecipitation as described above. S, suspension; A, attached. (C)
Src1/? or Src2/2 pOCs (1.0 3 106 cells) were either plated on Vn-coated dishes for 60
min (lanes 1 and 3) or re-cultured with equal number of vitamin D3-treated MB1.8
cells on tissue culture dishes to generate OCLs (lanes 2 and 4). After 12 h, OCLs were
purified as described in Materials and Methods. Cell lysates were immunoprecipi-
tated with anti-paxillin, followed by blotting with p-Tyr and anti-paxillin. Arrowhead
shows the position of paxillin.
Figure 7. M-CSF–induced intracellular sig-
naling in Src2/2 prefusion osteoclast-like
cells. Src1/? and Src2/2 pOCs were kept in
suspension or plated on Vn for 60 min in
the absence of serum, followed by treat-
ment with 5 nM M-CSF for the indicated
periods with or without PI 3-kinase inhibi-
tors. (A) Total cell lysates were immuno-
precipitated with anti-PYK2, anti-Cas, an-
tipaxillin, and anti-Src, and blotted with
antiphosphotyrosine (pTyr, left), anti-
PYK2, anti-Cas, antipaxillin, and anti-Src
antibodies (right). (B) Lysates were immunoprecipitated with anti–PLC-g2, blotted with anti-pTyr (top), then with anti–PLC-g2 an-
tibodies (middle). Part of the total cell lysates were used for immunodetection of c-Src (bottom). (C) Lysates were immunoprecipi-
tated with anti-Akt/PKB, blotted with anti–phospho-Akt/PKB, or anti-Akt/PKB antibodies. S, suspension; A, attached.Nakamura et al. Cross-regulation of avb3 and M-CSFR in Osteoclasts 367
skeletal reorganization. We previously reported on the role
of PYK2 and p130Cas in the avb3 integrin–mediated signal-
ing pathways (Duong et al., 1998; Lakkakorpi et al., 1999)
and on the involvement of PI 3-kinase in osteoclast adhe-
sion and spreading (Lakkakorpi et al., 1997). Since U73122
blocked the adhesion- and M-CSF–dependent cell spread-
ing of pOCs, we examined the tyrosine phosphorylation lev-
els of PLC-g1 and 2 in pOCs upon adhesion to Vn. Src1/? or
Src2/2 pOCs were either left in suspension or plated on Vn-
coated dishes. Cell lysates were analyzed by Western blot-
ting with antiphosphotyrosine antibodies after immunopre-
cipitation. In wild-type cells, PYK2, p130Cas, paxillin, and
both PLC-g1 and 2 became tyrosine phosphorylated paral-
leling the time course of cell spreading, i.e., peaking at 30
min after plating (Fig. 6 A). These data indicate that PLC-
g1 and 2 are downstream effectors of the integrin-mediated
signaling pathway. Furthermore, tyrosine phosphorylation
of these molecules after cell adhesion was absent in Src2/2
pOCs (Fig. 6 B), supporting the morphological observa-
tions shown in Fig. 1. The data thus implicated Src tyrosine
kinase as playing an essential role in osteoclast function by
mediating integrin-dependent signaling triggered by ligand
engagement.
We previously observed tyrosine phosphorylation of
paxillin in attached and spread Src2/2 OCLs under steady
state conditions (Duong et al., 1998). However, in this
study, we found that in Src2/2 pOCs, paxillin was not ty-
rosine phosphorylated immediately following adhesion
(Fig. 6 B). In order to reconcile these observations, we re-
cultured wild-type or Src2/2 pOCs with osteoblastic/stro-
mal MB1.8 cells for 12 h to form OCLs, and compared
them with the same number of pOCs both plated on Vn-
coated dishes for 60 min. Levels of tyrosine phosphory-
lated paxillin were analyzed in OCLs, after removal of
MB1.8 cells, and pOCs. As shown in Fig. 6 C, paxillin was
indeed tyrosine-phosphorylated in Src-deficient OCLs
(lane 4) as compared to Src2/2 pOCs (lane 3). It should be
noted that we consistently observed low yields of Src-defi-
cient OCLs after enzymatic treatment, which is probably
due to reduced spreading, as previously reported (Duong
et al., 1998). Nevertheless, our observations suggest that in
spread Src-deficient OCLs at steady state paxillin is phos-
phorylated, probably as a consequence of their interaction
with the osteoblasts/stromal cells. 
M-CSF Induces Tyrosine Phosphorylation of
PLC-g and Activation of PI 3-Kinase in
Src-deficient Osteoclasts
As shown above, M-CSF induces spreading in Src2/2 pre-
fusion osteoclasts in an avb3-dependent manner. There-
fore, we examined the downstream effectors involved in
M-CSF–dependent signaling in the absence of c-Src. Wild-
type and Src-deficient pOCs were plated on Vn-coated
dishes for 1 h to achieve maximal activation of the adhe-
sion-induced signals, and were then treated with M-CSF at
the indicated time (Fig. 7). Although M-CSF appeared to
further induce adhesion-dependent tyrosine phosphoryla-
Figure 8. M-CSF–induced association of avb3 in-
tegrin with signaling molecules in Src2/2 prefu-
sion osteoclast-like cells. (A) Cell adhesion and
M-CSF induce the association of b3 integrins
with signaling molecules in pOCs. Src1/? and
Src2/2 pOCs (1.5 3 106 cells per condition) were
plated on PL- or Vn-coated dishes. After culture
for 60 min, Src2/2 cells were treated with or with-
out 5 nM M-CSF for 5 min. Total cell lysates
were immunoprecipitated (IP) with anti–b3 inte-
grin antibodies, followed by immunoblotting
(IB) with anti–PLC-g2 (lanes 1–4), anti-PYK2
(lanes 5–8), anti–PI 3-kinase (lanes 9–12), anti–c-Src (lanes 13–
16), and anti–b3 integrin (lanes 17–20). The molecular masses of
marker proteins (in kD) are on the left. Positions of c-Src (arrow-
head) and of p85 subunit of PI 3-kinase (asterisk) are as indi-
cated. (B) PLC and PI 3-kinase inhibitors block M-CSF–induced
association of avb3 integrin with signaling molecules in Src-defi-
cient pOCs. Src2/2 pOCs (1.5 3 106 cells per condition) were
plated on Vn as described above, followed by incubation with ei-
ther U73122 (1 mM) or LY294002 (50 mM) for 40 min, then with 5
nM M-CSF. Lysates were immunoprecipitated with hamster anti–
murine b3 integrin antibodies (lanes 2–4, 6–8, 10–12, and 14–16)
or control hamster IgG (lanes 1, 5, 9, and 13), followed by blotting
with anti–PLC-g2 (lanes 1–4), anti-PYK2 (lanes 5–8), anti–PI
3-kinase (lanes 9–12), or anti–b3 integrin (lanes 13–16). p85 sub-
unit of PI 3-kinase (small arrowheads). C, control hamster IgGs.The Journal of Cell Biology, Volume 152, 2001 368
tion of PYK2, p130Cas, and paxillin in wild-type cells, ty-
rosine phosphorylation of these molecules was not de-
tected in M-CSF–treated Src-deficient pOCs (Fig. 7 A). In
contrast, M-CSF rapidly induced tyrosine phosphorylation
of PLC-g2 (Fig. 7 A) and PLC-g1 (data not shown) within
0.5 min in these cells, which gradually returned to basal
levels after 60 min, suggesting that tyrosine phosphoryla-
tion of both PLC-g isoforms by M-CSF is Src independent.
The M-CSF-induced PLC phosphorylation was found to
be transient, as compared to that of avb3-dependent PLC
phosphorylation in Src1/? pOCs (Fig. 6 A). 
PI 3-kinase activity was previously reported to be re-
quired for PLC-g activation (Falasca et al., 1998; Grata-
cap et al., 1998). In this study, LY294002, a selective PI
3-kinase inhibitor, inhibited M-CSF–mediated tyrosine
phosphorylation of PLC-g2 (Fig. 7 B), indicating that PI
3-kinase is an upstream mediator of PLC-g activation in
osteoclasts. Given the limitations of this cell system, in-
cluding relatively small cell numbers and short survival of
purified osteoclast-like cells in culture, which precluded
direct determination of PI 3-kinase activity, we examined
the activation of Akt/PKB as a downstream target of PI
3-kinase in these cells (Downward, 1998). Indeed, in Src2/2
pOCs (Fig. 7 C, right) as well as in wild-type cells (Fig. 7
C, left), M-CSF–induced phosphorylation of Akt/PKB,
which was blocked by the PI 3-kinase inhibitors, wortman-
nin (Fig. 7 C, left), and LY294002 (data not shown). We
also noted an increased level of Akt proteins in Src-defi-
cient pOCs (Fig. 7C). Using imaging densitometry, the ra-
tio of Akt protein levels in Src2/2 to wild-type pOCs was
estimated to be 1.7-fold. Furthermore, the specific activity
of tyrosine phosphorylated Akt in wild-type and Src2/2
pOCs upon treatment with M-CSF, at peak levels (2 min)
relative to basal levels (0 min), were estimated to be 4.4
and 3.9, respectively. This indicated that although Akt
proteins appeared to be induced in the absence of c-Src in
pOCs, the extent and time course of M-CSF-induced
phosphorylation of Akt were similar in wild-type and Src-
deficient prefusion osteoclasts (Fig. 7C). Interestingly, the
time course of PLC phosphorylation (Fig. 7B) is coinci-
dent with M-CSF-induced activation of PI 3-kinase (Fig.
7C). Since LY294002 blocked PLC-g phosphorylation
(Fig. 7B), these data indicated that in Src-deficient pOCs,
M-CSF activates PI 3-kinase, which subsequently leads to
PLC-g activation. Taken together, these findings impli-
cate PI 3-kinase and PLC-g in the M-CSF-dependent cy-
toskeletal organization in Src-deficient osteoclasts, which
further induces ligand engagement of avb3 integrins, for-
mation of adhesion contacts and cell spreading as shown
in Fig. 2 A.
Figure 9. Colocalization of avb3 integrin and PLC-g in M-CSF treated Src2/2 prefusion osteoclasts. Src2/2 pOCs were plated on Vn-
coated glass coverslips for 1 hr, then treated with 5 nM M-CSF for 30 min. Cells were fixed double stained with polyclonal anti-b3 inte-
grin and monoclonal anti-PLC-g1 or PLC-g2 antibodies. Pseudocolored confocal microscopic images of b3 integrins (a, d, in green) and
double staining of PLC-g1 (b, in red) or PLC-g2 (e, in red). Colocalization (c, f, in yellow) appears to be more prominent in the adhe-
sion contacts organized at the spreading edge of the cells. Images merged from optical sections of 4.7 mm thickness at the adhesion sur-
face of the cells. Bar, 10 mm.Nakamura et al. Cross-regulation of avb3 and M-CSFR in Osteoclasts 369
M-CSF–induced Recruitment of Downstream 
Mediators to b3 Integrins in Src-deficient Osteoclasts, 
Is Similar to Adhesion-dependent Recruitment in
Wild-Type Cells
Since previous reports demonstrated the association of
avb3 integrins with c-Src and PI 3-kinase in osteoclasts
(Hruska et al., 1995; Lakkakorpi et al., 1997), we examined
by coimmunoprecipitation with anti–b3 integrin antibodies
the adhesion-dependent association of avb3 with PLC-g, PI
3-kinase, c-Src, and PYK2. In pOCs, cell adhesion to Vn
increased the association of b3 integrins with PLC-g2, PI
3-kinase, PYK2, and c-Src (Fig. 8 A, lanes 1 and 2, 5 and 6,
9 and 10, and 13 and 14, respectively). These data suggest
that integrin–ligand engagement induces not only tyrosine
phosphorylation of these signaling molecules but also their
association with the integrin receptor.
On the other hand, in Src-deficient pOCs plated on Vn,
PLC-g2, PI 3-kinase, and PYK2 were only weakly coim-
munoprecipitated with the b3 integrins (Fig. 8 A, lanes 3, 7,
and 11), indicating that Src kinase is important for the ad-
hesion-dependent recruitment of various downstream me-
diators to the integrin receptor. However, association of
avb3 integrins with PLC-g2, PI 3-kinase, and PYK2 was
promoted in Src2/2 pOCs by treatment with M-CSF (Fig. 8
A, lanes 3 and 4, 7 and 8, and 11 and 12). These data sug-
gest that in the absence of c-Src, M-CSF–induced activa-
tion of PLC-g2 and PI 3-kinase was sufficient to further the
recruitment of PYK2 to avb3 receptors independent of ty-
rosine phosphorylation.
Additional evidence for the role of PLC and PI 3-kinase
in the M-CSF–dependent association of avb3 integrins with
their downstream effectors was provided by the fact that
either U73122 or LY294002 disrupted the recruitment of
PLC-g2, PYK2, and PI 3-kinase to b3 integrins in Src-defi-
cient pOCs (Fig. 8 B). These data supported the pharma-
cological findings suggesting that PI 3-kinase and PLC take
part in both, adhesion- and M-CSF-dependent signaling.
The findings also suggest that M-CSF modulates avb3 inte-
grin-dependent signaling via activation of PI 3-kinase and
PLC-g, leading to cytoskeletal reorganization and forma-
tion of integrin-associated adhesion contacts in osteoclasts.
To further test the involvement of avb3 integrins in
M-CSF–dependent spreading of Src2/2 pOCs, we exam-
ined the localization of avb3 in M-CSF–treated cells. As
shown in Fig. 9, b3 integrins (a and d, in green) colocalized
Figure 10. M-CSF–dependent
association of PLC-g2 and
PYK2 in osteoclasts. Src1/?
pOCs were cultured on Vn-
coated dishes for 60 min in the
absence of serum. (A) Total cell
lysates were immunoprecipi-
tated (IP) with anti–PLC-g2
(lane 1) and anti–PLC-g1 (lane
2), followed by blotting with
anti-PYK2 (left), anti–PLC-g2
(middle), or anti–PLC-g1
(right) antibodies. (B) Lysates
were immunoprecipitated with
anti-PYK2 mAb 11 (lane 1) and
anti-PYK2 N-19 antibodies
(lane 2), followed by blotting
with anti–PLC-g2 (left) or anti-
PYK2 (right). (C) Src1/? pOCs
were cultured on PL or Vn for
60 min with or without 1 mM
U73122. Lysates were immuno-
precipitated with anti–PLC-g2
and blotted with anti-PYK2
(left), and anti–PLC-g2 (right)
antibodies. (D) Lysates of Src1/?
OCLs were incubated with GST
fusion proteins containing NH2-
and COOH-terminal SH2 do-
mains or SH3 domains of PLC-
g1 and blotted with anti-PYK2
antibodies (top) or incubated
with GST fusion proteins of
NH2- or COOH-terminal do-
mains or kinase (K) domain of
PYK2 and blotted with anti–
PLC-g2 antibodies (bottom).
(E) Src2/2 pOCs (1.5 3 106 cells
per condition) were plated on Vn and treated without and with M-CSF. Adhesion of Src1/? pOCs on Vn was used as control. Lysates
were immunoprecipitated with anti–PLC-g2 and blotted with anti-PYK2, followed by anti–PLC-g2 antibodies (left) or immunopre-
cipitated with anti-N terminal PYK2 and blotted with anti–PLC-g2, followed by anti-PYK2 antibodies (right). Molecular weight
markers (in kD) are as indicated on the left. Positions of PYK2 (arrowhead) and of PLC-g (asterisk) are as indicated.The Journal of Cell Biology, Volume 152, 2001 370
with F-actin (Fig. 9 b, red) as well as PLC-g2 (Fig. 9 e,
red). Colocalization of b3 integrins and PLC-g were found
in adhesion contacts of the M-CSF-treated Src-deficient
pOCs plated on Vn (Fig. 9 c and f, in yellow).
Adhesion- and M-CSF–dependent Association of PYK2 
and PLC-g in Osteoclasts
We next examined which molecular interactions are im-
portant for the convergence of the integrin- and M-CSF–
dependent signals in prefusion osteoclasts in the absence
of c-Src. Since we were previously unable to demonstrate
stable interactions of PYK2 and PI 3-kinase in OCLs
(Duong et al., 1998), we examined the association of PYK2
with PLC-g in these cells. Both anti–PLC-g1 and 2 anti-
bodies coprecipitated PYK2 (Fig. 10 A) and anti-PYK2 an-
tibodies pulled down PLC-g2 (Fig. 10 B), supporting the in
situ association of the two proteins in OCLs. Furthermore,
upon adhesion to Vn a stronger association of PYK2 and
PLC-g was observed than in cells plated on PL (Fig. 10 C).
Moreover, in the presence of U73122 the association of
PYK2 and PLC-g2 was reduced to the level observed in
cells on PL (Fig. 10 C). These findings suggest that in os-
teoclasts, both integrin-dependent activation of PYK2 and
PLC-g2 and the phospholipase activity itself might be im-
portant for the stable interaction between these molecules.
To partially characterize the domains of PLC-g which
mediate binding to PYK2, GST fusion proteins encoding
the NH2- and COOH-terminal SH2 domains or the SH3
domain of PLC-g1 were incubated with lysates prepared
from OCLs. GST fusion protein containing the COOH-
terminal SH2 domain and the SH3 domain of PLC-g
bound to PYK2 from OCL lysates (Fig. 10 D, top), sug-
gesting that PLC-g could bind to either a tyrosine phos-
phorylated moiety or to a proline-rich region of PYK2.
Conversely, the COOH-terminal domain containing pro-
line-rich regions of PYK2 was found to bind to PLC-g2
(Fig. 10 D, bottom), supporting the above observations on
both the adhesion (phosphorylation)-dependent associa-
tion of PYK2 and PLC-g, as well as their constitutive in-
teraction. Additional studies will be conducted to further
analyze the structural features that are important for the
interaction of these two molecules.
Since we found that both integrin-dependent activation
of PYK2 and PLC-g2 and its phospholipase activity were
important for their interaction in wild-type pOCs, we thus
proceeded to examine the direct interaction of PYK2 and
PLC-g2 in M-CSF–treated Src-deficient pOCs. Although
PYK2 is not tyrosine phosphorylated in Src2/2 pOCs (Fig.
7 A), direct interaction of PYK2 and PLC-g2 was induced
in response to M-CSF (Fig. 10 E). This observation was re-
produced in three separate experiments and supports the
role of PLC activity in the integrin- and M-CSF–mediated
association with their downstream mediators (Fig. 8, A
and B). Furthermore, these data suggest that the direct as-
sociation of PYK2 and PLC-g might play an important
role in both M-CSF– and adhesion-dependent signaling
pathways in prefusion osteoclasts.
Discussion
Src kinases play an important role in cell adhesion and mi-
gration, in cell cycle control, and in cell proliferation and
differentiation (Thomas and Brugge, 1997). Moreover,
novel roles for Src kinases in the control of cell survival
and angiogenesis have recently emerged (Schlessinger,
2000). In this study, we examined integrin- and M-CSF–
mediated signaling pathways involved in the adhesion and
migration of osteoclast precursors, using Src1/? and Src2/2
pOCs formed in vitro. The findings indicate that c-Src is
essential for integrin-initiated signaling in these cells upon
ligand engagement, since the absence of c-Src causes im-
pairment in cell spreading associated with significant re-
duction in tyrosine phosphorylation of several adhesion/
signaling molecules including PYK2, p130Cas, paxillin, and
PLC-g. The involvement of Src family kinases in integrin-
mediated signaling pathway has been reported in Src2/2
Yes2/2Fyn2/2 triple mutant cells (Klinghoffer et al., 1999)
and macrophages derived from Hck2/2 Fgr2/2Lyn2/2 tri-
ple mutant mice (Meng and Lowell, 1998). Triple dele-
tions of Src family kinases are required to block the in-
tegrin-dependent signals in these cells, probably due
to functional overlap. On the other hand, in Src-deficient
fibroblasts, the vitronectin receptor-mediated traction forces
during cell migration were recently demonstrated to be se-
lectively modulated by c-Src (Felsenfeld et al., 1999). 
Osteoclasts abundantly express c-Src, as well as very low
levels of c-fyn, c-yes, and c-lyn (Horne et al., 1992). How-
ever, the absence of c-Src is sufficient to abolish bone re-
sorption in vivo, without reducing osteoclast number (So-
riano et al., 1991), suggesting that these members of the
Src kinase family do not compensate for the absence of
c-Src in osteoclast function, both in vivo and in vitro
(Horne et al., 1992). Indeed in Src2/2 pOCs, we found no
change in protein levels of c-yes and c-lyn, and a very small
increase (,2-fold) in c-fyn expression, and could not detect
these members of c-Src family kinases in immunoprecipi-
tates of avb3 integrins (data not shown). Nevertheless, we
show in this study that c-Src is not required for M-CSF–
induced cytoskeletal reorganization in prefusion osteoclast-
like cells. M-CSF induces cell spreading and migration,
along with tyrosine phosphorylation of PLC-g2 in Src2/2
pOCs, although it did not induce tyrosine phosphorylation
of PYK2 and p130Cas under the same conditions. We previ-
ously observed tyrosine phosphorylation of paxillin in at-
tached and spread Src2/2 OCLs (multinucleated osteoclast
like cells) under steady state conditions (Duong et al.,
1998). In this study, we examined adhesion-mediated sig-
naling immediately following the attachment of Src2/2
pOCs and found that paxillin is not tyrosine phosphory-
lated during initial adhesion process. To resolve this ap-
parent inconsistency, we re-cultured Src2/2 pOCs with os-
teoblastic/stromal cells to form OCLs, and found that
paxillin was indeed tyrosine phosphorylated in these at-
tached cells under steady state conditions. This observa-
tion suggests that in OCLs paxillin is phosphorylated by an
alternative kinase probably in response to stimuli received
from osteoblasts/stromal cells.
Our observations are consistent with a recent report
showing that PDGF-mediated signaling is similar in Src2/2
Yes2/2Fyn2/2 triple mutant fibroblasts and the wild-type
controls (Klinghoffer et al., 1999). In addition, our in vitro
findings of M-CSF–induced cell spreading and migration
of Src2/2 prefusion osteoclasts could be relevant to in vivo
observations on Src-deficient mice, where osteoclasts are
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of Src-deficient osteoclasts to spread and migrate in vivo
(Boyce et al., 1992) could reflect the influence of M-CSF
or other growth factors. Moreover, transgenic expres-
sion of kinase-deficient Src in Src2/2 mice rescued osteo-
clast function, indicating that Src may function in part as
an adaptor to recruit downstream signaling molecules
(Schwartzberg et al., 1997). Our findings apparently differ
from a previous report showing that M-CSF did not induce
cell spreading in Src-deficient osteoclasts derived from Src
knockout mice (Insogna et al., 1997). The difference could
be due to use in that study of adherent multinucleated pri-
mary osteoclasts in the presence of serum and bone mar-
row stromal cells. The present study used purified prefu-
sion osteoclast-like cells under serum-free condition, in
which M-CSF-mediated signaling could be enhanced.
The data presented here support the role of PLC-g in in-
tegrin-dependent regulation of cytoskeletal organization.
This is supported by induction of PLC-g tyrosine phosphor-
ylation upon cell adhesion and inhibition of cell spreading
in wild-type osteoclasts by a PLC inhibitor. These observa-
tions are consistent with previous studies showing that in-
tegrin–ECM interactions induce tyrosine phosphorylation
of PLC-g1 (Langholz et al., 1997) and PLC-g2 (Asselin et
al., 1997). It was also recently reported that phosphoryla-
tion of PLC-g1 at the tyrosine residue 783 is important for
regulation of cytoskeletal organization in fibroblasts (Yu
et al., 1998; Pei and Williamson, 1998), while PLC-g1 can
serve as a substrate of c-Src in in vitro kinase assays (Liao
et al., 1993; Nakanishi et al., 1993). Furthermore, PLC-g1–
null fibroblasts exhibit a more round-up morphology than
their normal counterparts (Ji et al., 1997). Taking advan-
tage of the crucial role of c-Src in osteoclasts, we demon-
strated that in these cells PLC-g is downstream of c-Src,
since adhesion does not induce tyrosine phosphorylation
of PLC-g1 and 2 in Src-deficient pOCs. 
This study points to interactions between adhesion- and
growth factor–initiated signal transduction, which seem to
play a role in cell spreading and migration. There are sev-
eral possible mechanisms for synergy between adhesion
and growth factor signaling pathways (Schwartz and Ing-
ber, 1994; Yamada and Miyamoto, 1995), for example acti-
vation of common downstream effectors. We suggest that
in prefusion osteoclasts PLC-g is one of the downstream
molecules, activated by adhesion- and M-CSF–dependent
signals, that lead to cytoskeletal reorganization. PLC-g is
activated either by cell attachment in a Src dependent
manner or by M-CSF-treatment which is not Src depen-
dent. The role of PLC is supported by pharmacological ev-
idence showing that PLC inhibitors block both adhesion-
and M-CSF–induced cell spreading. Previous studies have
implicated MAP kinases as candidates for this cross-sig-
naling (Chen et al., 1994; Zhu and Assoian, 1995); how-
ever, in osteoclasts, M-CSF did not activate MAP kinases
ERK1 and 2 in Src2/2 pOCs, and the MAP kinase kinase
inhibitor, PD98059, had little effect on M-CSF–induced
cell spreading of Src-deficient prefusion osteoclasts.
Another likely mechanism for the synergy between ad-
hesion- and growth factor–mediated signaling pathways is
the physical interaction (clustering) of key components of
both pathways, allowing the convergence of the two
(Thomas and Brugge, 1997; Giancotti and Ruoslahti,
1999). Coclustering of integrins and growth factor recep-
tors appears to require association with the cytoskeleton
and recruitment of downstream signaling molecules. Aggre-
gation of these molecules has been thought to bring both
adhesion- and growth factor-mediated signaling closer to a
threshold of manifest activity (Giancotti and Ruoslahti,
1999). Recent reports have documented the physical inter-
action of avb3 with the insulin, PDGF or VEGF receptors
in fibroblasts (Woodard et al., 1998; Soldi et al., 1999).
More recently, FAK was demonstrated to be an important
proximal link between PDGF and EGF receptors and b1
integrins during fibroblast chemotactic migration (Sieg, et
al., 2000). Interestingly, for chemotactic cell motility FAK
kinase activity is dispensible, while phosphorylation at
FAK Y397, the Src-kinase binding site, and the integrity of
the actin cytoskeleton are required for PDGF/EGF- and
integrin-mediated cell migration (Sieg, et al., 2000). 
In the case of prefusion osteoclasts, our data suggest
that M-CSF can modulate the localization of avb3 and its
interaction with downstream effectors in a c-Src–indepen-
dent manner. This is supported by the following findings:
first, M-CSF–induced cell spreading of Src2/2 pOCs de-
pends on attachment to Vn; second, echistatin, an avb3 in-
tegrin antagonist, blocks M-CSF–induced cell spreading;
third, in M-CSF–treated Src2/2 pOCs, b3 integrin localizes
to adhesion contacts along with PLC; and fourth, associa-
tion of avb3 with PYK2, PI 3-kinase, and PLC-g in Src2/2
prefusion osteoclasts is M-CSF dependent and PYK2
binds directly to PLC-g. These findings suggest that activa-
tion of M-CSF receptors result in the recruitment of intra-
cellular signaling molecules to avb3 integrins at adhesion
contacts. Furthermore, in Src-deficient cells, M-CSF in-
duces the association of b3 integrin engaged by its ex-
tracellular ligand with signaling molecules including PI
3-kinase, PLC-g, and PYK2, independent of PYK2 ty-
rosine phosphorylation. These interactions are blocked by
PLC or PI 3-kinase inhibitors. Therefore, our data suggest
that activation by either integrin ligands or growth factors
results in the physical recruitment of key components of
these pathways to adhesion contacts. On the other hand,
we could not convincingly demonstrate the presence of
M-CSF receptors in the avb3-associated immunocom-
plexes (data not shown). We are presently investigating fur-
ther the possible physical association of M-CSF receptor with
avb3 integrin in osteoclasts during chemotactic migration. 
The observations on PI 3-kinase are consistent with pre-
vious reports showing that growth factor receptors, e.g.,
PDGF (Kinashi et al., 1995), thrombopoietin (Zauli et al.,
1997), insulin (Guilherme et al., 1998), EGF (Adelsman et
al., 1999), and VEGF (Soldi et al., 1999) stimulate inte-
grin-mediated cell adhesion through a PI 3-kinase–depen-
dent pathway. In the case of osteoclasts, the association of
avb3 integrins with PI 3-kinase has been reported (Hruska
et al., 1995; Lakkakorpi et al., 1997). Present findings sug-
gest that PLC-g is a downstream effector of PI 3-kinase,
involved in the regulation of integrin-dependent signaling
by growth factors. Consistent with these observations,
Shibayama et al. (1999) reported recently that U73122
blocks IL-3–induced a4b1 and a5b1 integrin activation in
Baf3 cells.
An obvious question is how M-CSF–dependent activa-
tion of PI 3-kinase and PLC-g modulate integrin function.
FAK was demonstrated to bind to peptides that mimic the
b1 integrin cytoplasmic domains (Shaller et al., 1995). In
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beads pulled down the molecular complex that contains
FAK, c-Src, and PLC-g in capillary endothelial cells. Re-
cently, Zhang et al. (1999) reported that PLC-g1 can asso-
ciate with FAK. This association is mediated by tyrosine-
397 in FAK and the COOH-terminal SH2 domain of PLC-g1
and is dependent on cell adhesion. We found that PYK2,
a member of the FAK family kinases, is highly expressed
in osteoclasts and is tyrosine phosphorylated in a c-Src–
dependent manner upon avb3-mediated adhesion (Duong
et al., 1998). In addition, PYK2 localizes to podosomes,
the primary adhesion structures in osteoclasts (Duong et
al., 1998). In this study, PLC-g was found to associate with
PYK2 independent of PYK2 phosphorylation, probably
via the SH3 domain of PLC-g and the proline-rich do-
mains toward the COOH-terminal region of PYK2. Im-
portantly, this interaction was further enhanced upon os-
teoclast adhesion to Vn, possibly via interaction of the
COOH-terminal SH2 domain of PLC-g with tyrosine-402
in PYK2 (Schlaepfer et al., 1999). This interaction is sensi-
tive to the PLC-g inhibitor. Taken together, these data
suggest that in osteoclasts either integrin- or M-CSF–
mediated signals result in recruitment of PYK2 and PLC-g
to the integrin-associated complex at adhesion sites. Fur-
thermore, our data also suggest that PYK2 may function as
an adaptor recruiting other integrin-associated molecules,
including p130Cas and PLC-g, during M-CSF-induced Src2/2
osteoclast spreading and migration. In part, this observa-
tion is supported by a previous study in which kinase-defi-
cient c-Src was implicated to function as an adaptor, when
its transgenic expression rescued osteoclast function in
Src2/2 mice (Schwartzberg et al., 1997).
Questions that remain to be answered relate to how PI
3-kinase and PLC-g can mediate cell spreading and mi-
gration in response to growth factors and cytokines. PI
3-kinase-mediated activation of PLC- was suggested to be
important for PLC membrane targeting (Falasca et al., 1998).
One candidate molecule might be PKC, which is activated
by DAG, a product of PLC-g (Kolanus and Seed, 1997).
In FG human carcinoma cells, Klemke et al. (1994) dem-
onstrated a link between activation of EGF receptor ty-
rosine kinase, PKC, and integrin-dependent cell spread-
ing. The pleckstrin homology domain of PLC-g was shown
to preferentially recognize 3-phosphorylated phospho-
inositides, including PtdIns(3)P, PtdIns(3,4)P2, and PtdIns
(3,4,5)P3 (PIP3) and to lesser extent PtdIns(4,5)P2 (PIP2)
(Falasca et al., 1998; Kavran et al., 1998). Recent studies
revealed the cytoplasmic distribution of PtdIns(3)P to
endosomes, and PtdIns(3,4)P2 and PIP3 to plasma mem-
branes, and implicated roles of these PI 3-kinase products
in regulation of various processes, including endosome fu-
sion and motility, phagocytosis, pinocytosis, regulated exo-
cytosis, and cytoskeletal organization (Czech, 2000). Re-
cently, the local concentration of PIP2 was suggested to
control adhesion strength of the actin-based cytoskeleton
to plasma membrane, which also define cell shape and cell
movement (Raucher et al., 2000). Interestingly, the local-
ized adhesion energy in NIH3T3 cells was shown to be re-
duced by either EGF or PDGF, known stimuli that acti-
vate PLC-g, and this reduction could be blocked by
U73122 (Raucher et al., 2000). Together, these studies
suggest that PLC-g and PI 3-kinase, which mediate the cy-
toskeletal structure by changing local concentrations of
PIP2, PIP3, DAG, and calcium, could indirectly modulate
integrin function. 
In summary, we have demonstrated that in prefusion
osteoclasts: (a) c-Src is essential for integrin “outside-in”
signaling; (b) c-Src is not necessary for M-CSF–mediated
cytoskeletal reorganization; (c) PLC-g is a common down-
stream mediator for adhesion and growth factor signals;
and (d) M-CSF–initiated signaling modulates the avb3 in-
tegrin–ligand interaction and the recruitment of signaling
molecules to adhesion structures, possibly via PLC-g acti-
vation.
We thank the Visual Communication Department at Merck Research
Laboratories for preparing the figures and Dr. P.T. Lakkakorpi for help-
ing with confocal microscopy. 
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